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Retinoic acid (RA)-dependent homeostatic plasticity
and NMDA receptor-dependent long-term potentia-
tion (LTP), a form of Hebbian plasticity, both enhance
synaptic strength by increasing the abundance of
postsynaptic AMPA receptors (AMPARs). However,
it is unclear whether the molecular mechanisms
mediating AMPAR trafficking during homeostatic
and Hebbian plasticity differ, and it is unknown how
RA signaling impacts Hebbian plasticity. Here,
we show that RA increases postsynaptic AMPAR
abundance using an activity-dependent mechanism
that requires a unique SNARE (soluble NSF-attach-
ment protein receptor)-dependent fusion machinery
different from that mediating LTP. Specifically, RA-
induced AMPAR trafficking did not involve com-
plexin, which activates SNARE complexes contain-
ing syntaxin-1 or -3, but not complexes containing
syntaxin-4, whereas LTP required complexin. More-
over, RA-induced AMPAR trafficking utilized the Q-
SNARE syntaxin-4, whereas LTP utilized syntaxin-3;
both additionally required the Q-SNARE SNAP-47
and the R-SNARE synatobrevin-2. Finally, acute
RA treatment blocked subsequent LTP expression,
probably by increasing AMPAR trafficking. Thus,
RA-induced homeostatic plasticity involves a novel,
activity-dependent postsynaptic AMPAR-trafficking
pathway mediated by a unique SNARE-dependent
fusion machinery.
INTRODUCTION
The ability of a neuron to change its responsiveness to synaptic
inputs based on prior activity and experience is an essential
feature of the nervous system. These changes can occur in the
properties intrinsic to a neuron (i.e., membrane excitability) or442 Neuron 86, 442–456, April 22, 2015 ª2015 Elsevier Inc.at synapses where communication between two neurons is
achieved. Long-term potentiation (LTP) at synapses is thought
to underlie modification of neural circuits that drive behaviors,
enable learning, and encode memory. The known forms of
long-term synaptic plasticity include at least two main cate-
gories: Hebbian and homeostatic. Compared to Hebbian plas-
ticity, the mechanisms and functional significance of homeostat-
ic synaptic plasticity are less understood. One of the main open
questions is whether and how homeostatic synaptic plasticity in-
tersects with Hebbian synaptic plasticity at the functional and
molecular levels. Although operating under different computa-
tional rules and likely involving distinct molecular mechanisms,
homeostatic synaptic plasticity directly impacts the basal state
of synapses and is, therefore, likely to indirectly affect Hebbian
plasticity.
We have previously described a critical involvement of retinoic
acid (RA) in a form of homeostatic synaptic plasticity that is
induced by prolonged reduction in synaptic excitation (Aoto
et al., 2008; Chen et al., 2014; Sarti et al., 2013). Acting through
a distinct molecular mechanism, RA is capable of rapidly chang-
ing excitatory as well as inhibitory synaptic strength (Aoto et al.,
2008; Sarti et al., 2013). Thus, through its effects on both excita-
tion and inhibition, the synaptic action of RA may impact
Hebbian plasticity due to an altered synaptic excitation/inhibition
balance. Indeed, vitamin A deficiency (which depletes RA) im-
pairs hippocampal Hebbian plasticity and learning (Chiang
et al., 1998; Cocco et al., 2002; Misner et al., 2001). Moreover,
a study using a dominant-negative form of RARa expressed in
adult forebrain demonstrated impairments in AMPA receptor
(AMPAR)-mediated synaptic transmission, hippocampal LTP,
hippocampal-dependent social recognition, and spatial memory
(Nomoto et al., 2012). However, how RA-induced increases in
excitatory synaptic transmission affect Hebbian plasticity has
not been investigated.
At the molecular level, changes in synaptic AMPAR abundance
have been described for both RA-induced and Hebbian plasticity
(e.g., postsynaptic NMDA receptor [NMDAR]-dependent LTP).
The molecular machinery that governs AMPAR exocytosis is just
beginning tobeuncovered.Similar to presynaptic-activity-depen-
dent vesicle exocytosis (i.e., calcium-triggered neurotransmitter
release) (Su¨dhof and Rothman, 2009), postsynaptic AMPAR
exocytosis during LTP requires a SNARE (soluble NSF-attach-
ment protein receptor)-dependent membrane-fusion machinery
(Ahmad et al., 2012; Jurado et al., 2013). Specifically, both pro-
cesses require the R-SNARE synaptobrevin-2 (Syb-2) and the
SNARE-activating molecule complexin (Cpx) but differ in the Q-
SNAREs. Whereas calcium-triggered synaptic vesicle exocytosis
requires the Q-SNAREs SNAP-25 and syntaxin-1 (Stx-1), LTP-
induced AMPAR exocytosis requires SNAP-47 and syntaxin-3
(Stx-3) (Jurado et al., 2013). Thus, questions arise regarding
whether the complex formed by Syb-2, Stx-3, SNAP-47, and
Cpx represents a SNARE machinery universally used for all
forms of postsynaptic-activity-dependent AMPAR exocytosis
and whether the similarity and/or differences in the molecular
composition of the AMPAR exocytosis machinery between Heb-
bian and RA-induced plasticity accounts for a possible functional
impact of synaptic RA signaling on Hebbian plasticity.
In the present study, we examined the impact of RA on Heb-
bian plasticity in the hippocampus. We found that acute RA
treatment impairs subsequent expression of LTP and that this
impairment can be reversed by acute genetic deletion of RARa
or by inhibiting protein synthesis during RA treatment. Unexpect-
edly, we found that, similar to what occurs during LTP, synaptic
incorporation of AMPARs by RA requires synaptic activity and
NMDAR activation. Thus, we examined the potential conver-
gence of the molecular mechanisms underlying the activity-
dependent AMPAR insertion between LTP and RA-induced
AMPAR exocytosis. Using a short hairpin RNA (shRNA)-based
approach, we found that RA- and LTP-induced AMPAR inser-
tions are both regulated by activity and that both require some
of the same SNARE proteins, such as SNAP-47 and Syb-2, but
differ in two important components of the SNARE membrane-
fusion machinery. First, although Cpx is required for LTP, it
does not play a role in RA-induced AMPAR exocytosis. Second,
whereas Stx-3 (which interacts with Cpx) is required for LTP, Stx-
4 (which does not bind Cpx) is required for RA-induced AMPAR
exocytosis. Thus, our findings reveal a previously unidentified,
activity-dependent AMPAR exocytosis pathway, which utilizes
a unique vesicle fusion machinery that is distinct from that
used during LTP or during constitutive AMPAR exocytosis at
synapses.
RESULTS
Synaptic RA Signaling Blocks LTP Expression
To directly investigate the impact of synaptic RA signaling on
hippocampal LTP, we examined LTP induction at Schaffer
collateral-CA1 synapses after acute RA treatment (2-4 hr) in or-
ganotypic cultured hippocampal slices. Using a classical pairing
protocol, we reliably induced LTP in DMSO-treated slices but not
in RA-treated slices (Figure 1A; Figure S1A) (DMSO, 269.91% ±
31.57%; RA, 113.37% ± 7.68%; measured 55–60 min after
induction). Given the previously established role of RARa in syn-
aptic RA signaling (Aoto et al., 2008; Poon and Chen, 2008), we
asked whether this RA blockade of LTP is also mediated by
RARa. We injected lentiviruses expressing either wild-type
(active) or mutant (inactive) Cre recombinase (Cre or mCre,
respectively) into the CA1 pyramidal cell layer of cultured slicesobtained from conditional RARa KO mice (Chapellier et al.,
2002; Sarti et al., 2012), thus selectively deleting RARa in post-
synaptic neurons. Deletion of RARa did not impair LTP (Figures
1B and S1B) (mCre/DMSO, 308.77% ± 27.22%; Cre/DMSO,
261.34% ± 24.2%), consistent with previous observations that
RA/RARa signaling is specifically involved in homeostatic synap-
tic plasticity but not LTP (Aoto et al., 2008; Sarti et al., 2012). RA
treatment in mCre-infected neurons, similar to that in uninfected
neurons, greatly diminished LTP (Figures 1B and S1B) (mCre/
RA, 152.22% ± 27.22%), whereas deletion of RARa rescued
the ability of neurons to undergo LTP following RA treatment
(Figures 1B and S1B) (Cre/RA, 322.67% ± 73.21%). Thus,
although RA/RARa signaling is not required for LTP, RA’s action
on excitatory synapses prevents subsequent induction of LTP,
and this effect of RA operates by an RARa-mediated signaling
pathway.
RA is traditionally considered a key transcription factor during
development (Maden, 2007), but it also controls synaptic
strength by regulating local protein synthesis in neuronal den-
drites (Maghsoodi et al., 2008; Poon and Chen, 2008). To test
whether RA blocks LTP induction through an action that also
requires protein synthesis, we examined the effect of a protein
synthesis blocker, anisomycin, on LTP. Pretreating slices with
anisomycin for 2 hr (which blocks the effect of RA on synaptic
strength; Aoto et al., 2008) rescued LTP in RA-treated slices (Fig-
ures 1C and S1C) (RA, 129.52% ± 12.62%; anisomycin + RA,
217.22% ± 21.42%), confirming the hypothesis that RA blocks
LTP via a protein synthesis-dependent process. Anisomycin
treatment, however, did not affect LTP under control conditions,
demonstrating that its effect is specific to the RA condition (Fig-
ures 1C and S1C) (anisomycin, 225.30% ± 21.99%; measured
55–60 min after induction). To further control for potential non-
specific effects of anisomycin, we repeated the same series of
experiments with another protein synthesis inhibitor, cyclohexi-
mide. Similar to anisomycin, cycloheximde co-treated with
RA blocked the effect of RA on LTP (Figures S1D and S1E)
(RA, 110.70% ± 7.21%; cycloheximide, 242.53% ± 23.12%;
cycloheximide + RA, 198.75% ± 17.50%).
RA-Induced AMPAR Insertion Is Activity Dependent
One interpretation for the impaired LTP after RA treatment is that
RA increases excitatory synaptic strength and thereby prevents
the subsequent potentiation of synapses evoked by LTP-induc-
tion protocols. Therefore, we wanted to first confirm that RA,
indeed, increased synaptic excitation under our experimental
conditions. Consistent with previous results (Aoto et al., 2008),
RA increased the amplitude, but not the frequency, of miniature
excitatory postsynaptic currents (mEPSCs) from hippocampal
CA1 neurons (Figure 2A) (DMSO, 12.85 ± 0.33 pA, 0.78 ±
0.12 Hz; RA, 15.10 ± 0.48 pA, 0.70 ± 0.09 Hz). We previously re-
ported that RA potentiates the mEPSC amplitude of primary
cultured neurons in a multiplicative fashion (Aoto et al., 2008),
similar to synaptic scaling in response to activity blockade (Tur-
rigiano et al., 1998). We wondered whether RA-induced potenti-
ation of mEPSC in organotypic slices follows the same pattern.
When ranked mEPSC amplitudes of RA-treated responses
were plotted against those of DMSO-treated responses,
we noticed that, for more than 95% of mEPSCs that exhibitNeuron 86, 442–456, April 22, 2015 ª2015 Elsevier Inc. 443
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Figure 1. Acute RA Treatment Impairs Hip-
pocampal LTP
(A) Example traces (left) and summary graph
(right) of LTP in DMSO- or RA-treated hippocam-
pal CA1 pyramidal neurons from cultured slices
(p < 0.0001).
(B) Example traces and summary graph of LTP
in CA1 pyramidal neurons with RARa deletion.
Lentivirus expressing Cre or mCre was injected
into the CA1 regions of the hippocampal slices
obtained from RARa conditional KO mice. LTP
was examined 7–10 days after viral injection
(mCre/DMSO versus mCre/RA, p < 0.005; Cre/
DMSO versus Cre/RA, p > 0.5; mCre/RA versus
Cre/RA, p < 0.0001).
(C) Example traces and summary graph of LTP in
CA1 pyramidal neurons treated with anisomycin
(aniso), RA, or both (RA versus anisomycin, p <
0.005; anisomysin versus RA + anisomycin, p >
0.9).
Scale bars in (A)–(C): 20 pA, 20ms. Black bars in all
summary graphs indicate the time window for LTP
magnitude quantification. All graphs represent
average values ± SEM.mEPSC amplitudes of <30 pA, the increase in mEPSC amplitude
appeared to be strictly multiplicative (i.e., scaled; Figure S2A1).
However, at large mEPSC amplitudes (30–60 pA, less than 5%
of the total population), supralinear and sublinear potentiation
was observed (Figure S2A2). Thus, RA-mediated potentiation
primarily follows a multiplicative pattern for the majority of
mEPSCs. The complexity of the potentiation pattern associated
with a small subset of responses at higher amplitudes may
reflect RA’s heterogeneous action at a subset of synapses. We
speculate that the differences in pathway/input type and the
states of the synapses, which are better preserved in organo-
typic slices, may underlie such complexity.
To test whether RA enhances both AMPAR-mediated and
NMDAR-mediated components of excitatory synaptic trans-444 Neuron 86, 442–456, April 22, 2015 ª2015 Elsevier Inc.mission, we recorded dual-component
mEPSCs in the absence of external
Mg2+ (Arendt et al., 2013). RA treatment
did not result in any significant increase
in the NMDAR-mediated component of
mEPSCs (DMSO, 2.03 ± 0.22 pA; RA,
2.38 ± 0.20 pA), despite the persistent
increase in the AMPAR-mediated com-
ponent as measured in this analysis
(DMSO, 10.56 ± 0.39 pA; RA, 12.33 ±
0.59 pA) (Figure 2B). Additionally, we
examined the AMPAR/NMDAR response
ratio of evoked EPSCs (eEPSCs) and
found that RA significantly increased
the AMPAR/NMDAR ratio (Figure 2C)
(DMSO, 1.12 ± 0.12; RA, 1.63 ± 0.17).
We did not observe any effect of RA on
the paired-pulse ratio or passive mem-
brane properties (Figures S2B and S2C).
Thus, RA selectively enhances AMPAR-mediated synaptic responses due to specific promotion of
AMPAR insertion (Aoto et al., 2008).
AMPAR insertion during LTP requires activity and NMDAR
activation (Collingridge et al., 1983; Huganir and Nicoll, 2013).
Next, we asked whether the RA-mediated increase in the synap-
tic content of AMPARs also required activity and NMDAR activa-
tion. During acute RA treatment, we co-applied hippocampal
slices with the voltage-gated sodium channel blocker tetrodo-
toxin (TTX) to block neuronal activity. Surprisingly, TTX co-
applied with RA (<4 hr) blocked the enhancement of the mEPSC
amplitude by RA (Figure 2D) (DMSO, 10.58 ± 0.30 pA; RA,
12.65 ± 0.24 pA; RA + TTX, 11.24 ± 0.31 pA). Note that this pro-
tocol differs from the TTX treatment used to induce homeostatic
plasticity that involves a chronic pretreatment of neurons, not an
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Figure 2. RA Increases AMPAR-Mediated Excitatory Synaptic Transmission through an Activity-Dependent Mechanism
(A) Trace examples (left), amplitude (middle), and frequency (right) quantification ofmEPSCs recordings fromDMSO- or RA-treated CA1 pyramidal neurons (***p <
0.0005). Scale bars, 10 pA, 1 s. sec, seconds.
(B) Dual-component mEPSC recordings in CA1 pyramidal neurons treated with DMSO or RA. Left: trace examples of AMPA-only and dual-component mEPSCs.
Right: quantification of AMPA and NMDA mEPSC amplitude (*p < 0.05). NMDA mEPSC component was calculated by subtracting the average AMPA mEPSC
component from the average dual mEPSC component. Scale bars, 4 pA, 10 ms.
(C) Ratio of AMPAR- to NMDAR-mediated EPSCs in CA1 pyramidal neurons treated with DMSO or RA (*p < 0.05). Representative EPSCs recorded at 60 mV
and +40 mV are shown at the left. Scale bars, 50 pA, 20 ms.
(D) Trace examples (left) and quantification of mEPSC amplitude and frequency obtained from CA1 pyramidal neurons treated with 4 hr of DMSO, RA, RA + TTX,
or RA + APV (***p < 0.0001). Scale bars, 10 pA, 1 s.
All graphs represent average values ± SEM.
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Figure 3. RA Treatment Activates Postsynaptic Silent Synapses by Promoting AMPAR Insertion into the Synaptic Membrane
(A) Schematic diagrams of various treatment protocols used in the experiments for this figure.
(B–D) Trace examples and scatterplots of eEPSCs recorded from CA1 pyramidal neurons treated with DMSO (B), TTX (60 hr) (C), and RA (4 hr) (D) at 60 mV
and +40 mV. Scale bars, 10 pA, 10 ms. sec, seconds.
(E) Failure rate of eEPSCs recorded at 60 mV and +40 mV from DMSO-, TTX-, and RA- treated neurons (***p < 1 3 109).
(legend continued on next page)
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acute addition of TTX. To address whether NMDAR activity was
also required for AMPAR insertion, in amanner similar to LTP, we
co-applied APV acutely with RA (<4 hr) to specifically block
NMDAR activation and found that this treatment also blocked
the increase in mEPSC amplitude by RA (Figure 2D) (DMSO,
11.17 ± 0.28 pA; RA, 13.81 ± 0.51 pA; RA + APV, 11.31 ±
0.35 pA). Thus, similar to LTP-induced postsynaptic AMPAR
insertion, the RA-mediated increase in post-synaptic AMPARs
also requires NMDAR activation. In other words, RA only en-
hances the strength of actively used synapses, possibly as a
mechanism to ensure that the RA-mediated AMPAR insertion
does not occur at synapses that are not being used.
RA Activates Silent Synapses by Promoting AMPAR
Insertion
LTP induction is known to not only increase the abundance of
AMPARs at synapses that already contain AMPARs but also
activate ‘‘silent’’ synapses lacking AMPARs (but containing
NMDARs) by inserting AMPARs into these synapses (Isaac
et al., 1995; Liao et al., 1995). Given the similar requirement of
NMDAR activation for both LTP-induced and RA-induced
AMPAR insertion at synapses, we were curious as to whether
RA is capable of activating silent synapses by promoting inser-
tion of AMPARs into NMDAR-only synapses. To induce forma-
tion of silent synapses, we applied a protocol used previously
in cultured hippocampal slices—prolonged silencing of neural
network activity with TTX for 60 hr—that reliably induces forma-
tion of silent synapses containing only NMDARs (Arendt et al.,
2013) (Figure 3A). For the detection of silent synapses, cells
were clamped at their resting membrane potential (60 mV),
and excitatory synaptic transmission was elicited with a weak
stimulus that produced failures in about 50% of trials. Epochs
of 50 trials of transmission were recorded at60mV and +40mV
for each cell, and the failure rate at each of these two holding po-
tentials was computed.
In slices cultured under control conditions, the failure rate
was comparable between the negative and the positive hold-
ing potentials (Figures 3B and 3E) (60 mV, 55.73% ±
2.59%; +40 mV, 53.82% ± 3.83%), indicating that most synap-
ses are active and contained both AMPARs and NMDARs at
this stage of development. Consistent with previous work
(Arendt et al., 2013), prolonged TTX treatment induced formation
of silent synapses, indicated by the significantly higher failure
rate at 60 mV than at the +40 mV holding potential (Figures
3C and 3E) (60 mV, 49.29% ± 2.28%; +40 mV, 20.61% ±
2.74%), which suggests that a larger proportion of synapses
contain only NMDARs but not AMPARs. It is important to note
that acute RA treatment, per se, did not induce silent synapses
(Figures 3D and 3E) (60 mV, 49.18% ± 3.76%; +40 mV,
48.57% ± 5.10%).(F) Failure rate of eEPSCs recorded at 60 mV and +40 mV from neurons trea
with wash/RA + APV (***p < 0.0005).
(G) Top: example traces of mEPSC recordings. Bottom: quantification of amplitud
DMSO, TTX, and TTX with wash/RA (**p < 0.01; ***p < 0.001). Scale bars, 15 pA
(H) Top: example traces of mEPSC recordings. Bottom: quantification of amplitud
DMSO, TTX and TTX with no wash/RA (**p < 0.01; ***p < 1 3 106). Scale bars,
All graphs represent average values ± SEM.We then applied RA to slices that had been treated with TTX
for 60 hr. Washing out TTX during RA treatment to restore
network activity converted silent synapses to active synapses,
as evidenced by the similar failure rates at 60 mV and +40 mV
(Figure 3F) (60-hr TTX with wash + RA: 60 mV, 50.05% ±
2.38%; +40 mV, 48.82% ± 3.71%). This conversion of silent to
functional synapses by RA requires intact network activity as
well as NMDAR activation because the presence of TTX or
APV during RA treatment prevented the activation of silent syn-
apses (Figure 3F) (60-hr TTX with no wash + RA: 60 mV,
49.16% ± 4.12%; +40 mV, 26.76% ± 3.25%; 60-hr TTX with
wash + RA + APV: 60 mV, 52.80% ± 4.30%; +40 mV,
28.51% ± 4.87%). It is important to note that simply washing
out TTX without RA treatment was not sufficient to convert silent
synapses into active synapses within the 4-hr time window used
for our experiments (Figure 3F) (60-hr TTX with wash: 60 mV,
54.22% ± 4.00%; +40 mV, 31.68% ± 3.60%).
In addition to evoked EPSCs, we also examined mEPSCs
during silent-synapse activation. As expected, homeostatic
synaptic plasticity induced by prolonged TTX treatment mani-
fested as an increase in mEPSC amplitude (Figure 3G)
(DMSO, 11.58 ± 0.27 pA; 60-hr TTX, 14.06 ± 0.62 pA) without
changes in mEPSC frequency (Figure 3G) (DMSO, 0.43 ±
0.05 Hz; 60-hr TTX, 0.37 ± 0.05 Hz) (Turrigiano et al., 1998).
By contrast, following prolonged TTX treatment, incubation
with RA (in the absence of TTX) activated silent synapses, as
evidenced by a significant increase in the mEPSC frequency
(Figure 3G) (60-hr TTX with wash + RA, 0.66 ± 0.07 Hz). Notably,
RA treatment after prolonged TTX treatment also decreased the
mEPSC amplitude (Figure 3G) (60-hr TTX with wash + RA,
12.06 ± 0.54 pA), presumably because newly activated silent
synapses have smaller mEPSC amplitudes. Thus, we plotted
ranked amplitudes of the three groups (Figure S3A). Indeed,
while prolonged TTX treatment induced synaptic scaling, re-
sponses recorded in neurons that received RA after TTX treat-
ments displayed a large population of small amplitudes that
are not apparently potentiated, likely representing the popula-
tion of newly activated silent synapses (Figure S3A). Similar to
the failure rate experiments described earlier, the presence of
TTX during RA treatment prevented the activation of silent syn-
apses, as evidenced by a lack of change in mEPSC frequency
(Figure 3H) (amplitude: DMSO, 10.93 ± 0.25 pA; 60-hr TTX,
13.70 ± 0.41 pA; 60-hr TTX with no wash + RA, 12.66 ±
0.51 pA; frequency: DMSO, 0.37 ± 0.04 Hz; 60-hr TTX, 0.42 ±
0.05 Hz; 60-hr TTX with no wash + RA, 0.34 ± 0.07 Hz). Ranked
plots of the mEPSC amplitudes confirmed this notion in that the
TTX and the TTX with no wash + RA groups showed a similar
degree of potentiation of mEPSC amplitudes (Figure S3B).
Moreover, we previously showed that generation of silent syn-
apses by prolonged TTX treatment leads to a greaterted with TTX plus wash/RA, TTX with no wash/RA, TTX with wash, and TTX
e and frequency of mEPSCs recorded fromCA1 pyramidal neurons treatedwith
, 1 s.
e and frequency of mEPSCs recorded fromCA1 pyramidal neurons treatedwith
15 pA, 1 s.
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potentiation when LTP is induced subsequently (Arendt et al.,
2013). This enhancement of LTP was completely reversed to
an impairment of LTP if the slices were incubated with RA after
TTX washout (Figures S3C and S3D) (control, 224.21% ±
30.24%; 60-hr TTX, 406.67% ± 44.38%; 60-hr TTX with
wash + RA, 142.64% ± 17.21%), which is consistent with
RA’s action in converting silent synapses into functional synap-
ses. By contrast, if RA was applied without TTX washout, the
greater LTP was maintained (Figures S3C and S3D) (60-hr
TTX with no wash + RA, 425.93% ± 73.96%).
Taken together, the results obtained with both miniature and
evoked synaptic responses strongly suggest that RA-induced
AMPAR insertion into synapses shares common features with
LTP-induced AMPAR insertion, in that both processes require
neuronal activity and NMDAR activation. Although this finding
may appear at first glance to be counterintuitive, given that
RA-dependent homeostatic plasticity is induced by the inactiva-
tion of synaptic activity, not by increased synaptic activity, it is
remarkable that expression of homeostatic plasticity neverthe-
less requires a suspension of chronic inactivity—continuous
blockade of synaptic activity in fact prevents homeostatic
plasticity.
Postsynaptic Cpx Is Not Required for RA-Mediated
AMPAR Delivery to the Synapse
Intrigued by the common requirement of NMDAR activation
for AMPAR insertion in the LTP and RA pathways, we sought
to further dissect the steps downstream of NMDAR activation
in RA-induced AMPAR insertion. Similar to presynaptic neuro-
transmitter vesicle release, postsynaptic vesicle exocytosis
is thought to involve assembly of SNARE complexes and
SNARE-binding proteins. Indeed, Cpx, an important co-factor
for synaptotagmin-triggered presynaptic vesicle fusion (McMa-
hon et al., 1995; Reim et al., 2001), is required for the activity-
regulated exocytosis of postsynaptic AMPAR-containing vesi-
cles during LTP, but not for constitutive AMPAR insertion
(Ahmad et al., 2012). Therefore, we investigated the involvement
of Cpx in the RA-induced increase of excitatory synaptic
transmission using an shRNA-mediated knockdown (KD) of
Cpx (Ahmad et al., 2012; Maximov et al., 2009). Specifically, a
multi-promoter lentivirus encoding two shRNAs targeting both
Cpx1 and Cpx2 was injected into the CA1 pyramidal cell layer
of cultured hippocampal slices to knock down postsynaptic
Cpx. We found that, consistent with previous observations
(Ahmad et al., 2012), postsynaptic Cpx was not required for
maintaining basal synaptic transmission (Figure 4A) (mEPSC
amplitude: control, 11.04 ± 0.38 pA; Cpx KD, 10.23 ± 0.30 pA).
Notably, acute RA treatment significantly increased the mEPSC
amplitude in both control and neighboring Cpx KD neurons (Fig-
ure 4A) (mEPSC amplitude in RA: control, 12.81 ± 0.35 pA; Cpx
KD, 12.77 ± 0.40 pA). Thus, unlike the LTP pathway, RA-induced
AMPAR delivery to the synapse does not require Cpx.
Postsynaptic Syb-2 and SNAP-47 Are Both Required for
RA-Mediated AMPAR Delivery to the Synapse
Previous studies using postsynaptic loading of the light chains of
botulinum toxin B or tetanus toxin (which cleave the R-SNARE
Syb-2) (Link et al., 1992; Schiavo et al., 1992) and, more recently,448 Neuron 86, 442–456, April 22, 2015 ª2015 Elsevier Inc.studies using Syb-2 KOmice and postsynaptic rescue have sug-
gested that this R-SNARE protein is critical for the delivery of
AMPARs to the plasma membrane during LTP (Jurado et al.,
2013; Lledo et al., 1998). To examine the involvement of Syb-2
in RA-mediated AMPAR synaptic delivery, we injected a lenti-
virus expressing tetanus toxin light chain (tetTox) (Xu et al.,
2012) into postsynaptic CA1 neurons in cultured hippocampal
slices. RA strongly increased the mEPSC amplitude in neigh-
boring uninfected neurons (Figure 4B) (mEPSC amplitude:
DMSO, 9.99 ± 0.29 pA; RA, 12.88 ± 0.46 pA) but had no effect
on tetTox-expressing neurons (Figure 4B) (mEPSC amplitude:
DMSO, 11.45 ± 0.49 pA; RA, 10.86 ± 0.34 pA), indicating a critical
involvement of postsynaptic Syb-2 in RA-induced AMPAR
exocytosis.
Two target Q-SNAREs—syntaxins and SNAP-25 or its homo-
logs—are involved in vesicle exocytosis. Presynaptically,
SNAP-25 is specifically required for neurotransmitter release
(Su¨dhof and Rothman, 2009); postsynaptically, SNAP-25 is
essential for normal surface expression of NMDARs (Jurado
et al., 2013; Lau et al., 2010). However, for activity-dependent
surface delivery of AMPARs during LTP, SNAP-47, but not
SNAP-25, is critical (Jurado et al., 2013). Therefore, we exam-
ined the involvement of SNAP-47 in RA-mediated AMPAR
insertion using the same shRNA lentiviral constructs that were
previously characterized (Jurado et al., 2013). Postsynaptic
KD of SNAP-47 completely abolished the RA-induced increase
in mEPSC amplitude (Figure 4C) (SNAP-47 KD: DMSO, 10.83 ±
0.43 pA; RA, 11.10 ± 0.40 pA), whereas neighboring uninfected
neurons responded robustly to RA treatment (Figure 4C)
(DMSO, 10.89 ± 0.30 pA; RA, 13.28 ± 0.45 pA). The deficits
observed in the SNAP-47 KD neurons were fully rescued by
simultaneous expression of an shRNA-resistant wild-type
SNAP-47 (SNAP-47 Rep; Figure 4D) (control/DMSO, 10.52 ±
0.22 pA; control/RA, 12.72 ± 0.50 pA; SNAP-47 Rep/DMSO,
10.32 ± 0.20 pA; SNAP-47 Rep/RA, 12.00 ± 0.29 pA). Thus,
both LTP- and RA-induced exocytosis of AMPAR-containing
vesicles requires the R-SNARE Syb-2 and the Q-SNARE
SNAP-47.
Postsynaptic Syntaxin-4, but Not Stx-3, Is Required for
RA-Mediated Synaptic Delivery of AMPARs
Next, we focused on syntaxin Q-SNAREs. Syntaxins contain a
conserved N-terminal peptide that binds to Sec1/Munc18-like
proteins (SM proteins), followed by an Habc domain, a SNARE
motif, and a carboxyl-terminal (C-terminal) transmembrane
region (Figure 5A). We systematically examined Stx-1, Stx-3,
and syntaxin-4 (Stx-4) because all of these isoforms are highly
expressed in neurons but seem to mediate distinct types of
vesicle fusion. Stx-1 forms the SNARE complex with Syb-2
and SNAP-25 that mediates transmitter release (Su¨dhof and
Rothman, 2009) but is not required for postsynaptic constitu-
tive AMPAR exocytosis during basal synaptic transmission or
for regulated AMPAR insertion induced by LTP (Jurado et al.,
2013). We found that, similar to these previous observations,
the postsynaptic Stx-1 KD had no effect on the basal mEPSC
amplitude or on the RA-mediated increase in mEPSC ampli-
tude (Figure 5A) (control/DMSO, 10.94 ± 0.26 pA; control/RA,
12.87 ± 0.56 pA; Stx-1 KD/DMSO, 10.71 ± 0.37 pA; Stx-1
04
8
12
0
4
8
12
0
0.2
0.4
0.6
0
0.2
0.4
0.3
0.1
m
E
P
S
C
 a
m
pl
itu
de
 (p
A
)
m
E
P
S
C
 a
m
pl
itu
de
 (p
A
)
m
E
P
S
C
 fr
eq
ue
nc
y 
(H
z)
m
E
P
S
C
 fr
eq
ue
nc
y 
(H
z)
***
n.s.
n.s.
***
RA - + - +
control SNAP-47 KD
RA - + - +
control SNAP-47 KD
RA - + - +
control SNAP-47 Rep
RA - + - +
control SNAP-47 Rep
n.s.
***
n.s. n.s.
n.s. n.s.
33/3 36/3 30/3 26/3 33/3 36/3 30/3 26/3
25/3 20/3 34/3 22/3 25/3 20/3 34/3 22/3
0
0.2
0.4
0.6
m
E
P
S
C
 fr
eq
ue
nc
y 
(H
z)
0
4
8
12
0
0.2
0.4
0.6
m
E
P
S
C
 a
m
pl
itu
de
 (p
A
)
m
E
P
S
C
 fr
eq
ue
nc
y 
(H
z)
RA - + - +
control Cpx KD
RA - + - +
control tetTox
RA - + - +
control Cpx KD
25/3 25/3 28/3 34/3
23/3 22/3 27/3 20/3
25/3 25/3 28/3 34/3
n.s.
***
0
4
8
12
m
E
P
S
C
 a
m
pl
itu
de
 (p
A
)
RA - + - +
control tetTox
23/3 22/3 27/3 20/3
***
*
n.s.
***
n.s. n.s.
* n.s.
A
B
C
D
n.s.
n.s.
n.s.
n.s.
Figure 4. Syb-2 and SNAP-47, but Not Cpx,
Are Required for RA-Induced Increase in
Excitatory Synaptic Transmission
(A) Amplitude and frequency analysis of mEPSCs
recorded from CA1 pyramidal neurons infected
with lentivirus expressing Cpx KD constructs and
treated with DMSO or RA. Neighboring uninfected
neurons were recorded as controls (*p < 0.05;
***p < 0.001; n.s., not significant).
(B) Amplitude and frequency analysis of mEPSCs
recorded from CA1 pyramidal neurons expressing
tetanus toxin light chain (tetTox) treated with
DMSO or RA. Neighboring uninfected neurons
were recorded as controls (*p < 0.05; ***p < 1 3
105; n.s., not significant).
(C) Amplitude and frequency analysis of mEPSCs
recorded from CA1 pyramidal neurons expressing
SNAP-47 KD construct treated with DMSO or RA.
Neighboring uninfected neurons were recorded as
controls (***p < 1 3 104; n.s., not significant).
(D) Amplitude and frequency analysis of mEPSCs
recorded from CA1 pyramidal neurons infected
with lentivirus expressing both SNAP-47 KD and
SNAP-47 Rep treated with DMSO or RA. Neigh-
boring uninfected neurons were recorded as
controls (***p < 1 3 104; n.s., not significant).
All graphs represent average values ± SEM.
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Figure 5. Stx-4, but Not Stx-1 or Stx-3, Is Required for RA-Induced Increase in Excitatory Synaptic Transmission
(A) Analysis of amplitude and frequency of mEPSCs recorded from control and Stx-1 KD CA1 pyramidal neurons in cultured hippocampal slices treated with
DMSO or RA (**p < 0.01; n.s., not significant). Top: schematic of Stx-1 showing its functional domains. Habc, Habc domains; TMR, transmembrane domain.
Green indicates Cpx-binding sequence.
(B) Summary of mEPSC amplitude and frequency analysis from control and Stx-3 KD CA1 pyramidal neurons in cultured hippocampal slices treated with DMSO
or RA (**p < 0.01; ***p < 0.0005; n.s., not significant). Top: schematic of Stx-3 showing its functional domains.
(C) Summary of mEPSC amplitude and frequency analysis from control and Stx-4 KD CA1 pyramidal neurons in cultured hippocampal slices treated with DMSO
or RA (*p < 0.05; ***p < 1 3 106; n.s., not significant). Top: schematic of Stx-4 showing its functional domains (red indicates non-Cpx-binding sequence).
(D)Summarygraph (left) and traceexamples (right) of LTP recorded fromCA1pyramidal neuronexpressingStx-3KDorStx-4KDconstructs.Neighboringuninfected
neurons were recorded as controls. Black bar in the summary graph indicates the time window for LTP magnitude quantification. Scale bars, 20 pA, 10 ms.
(E) Scatterplots of LTP obtained from individual experiments summarized in (D) (**p < 0.01; n.s., not significant).
All error bars represent mean ± SEM.
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KD/RA, 12.13 ± 0.40 pA). Stx-3, like Stx-1, binds Cpx via a
specific 12-amino-acid stretch within the SNARE motif (Fig-
ures 5A and 5B; Pabst et al., 2000) but differs from Stx-1 in
that Stx-3 is required for AMPAR exocytosis during LTP,
whereas Stx-1 is not (Jurado et al., 2013). We confirmed
that the Stx-3 KD had no effect on basal synaptic transmis-
sion, but we were surprised to find that the Stx-3 KD did not
block the RA-induced increase in postsynaptic AMPAR re-
sponses, which is different from its effect on LTP (Figure 5B)
(mEPSC amplitudes: control/DMSO, 10.24 ± 0.21 pA; con-
trol/RA, 12.04 ± 0.43 pA; Stx-3 KD/DMSO, 10.36 ± 0.36 pA;
Stx-3 KD/RA, 12.33 ± 0.60 pA). In stark contrast, the Stx-4
KD completely abolished the RA-induced enhancement of
AMPAR-mediated responses without affecting basal transmis-
sion (Figure 5C) (control/DMSO, 10.63 ± 0.21 pA; control/RA,
13.39 ± 0.39 pA; Stx-4 KD/DMSO, 10.25 ± 0.28 pA; Stx-4
KD/RA, 10.64 ± 0.17 pA).
It is interesting that Stx-4 was previously shown to mediate in-
sulin-dependent glucose transport through regulation of mem-
brane GLUT4 trafficking (Dugani and Klip, 2005; Olson et al.,
1997). Moreover, a study using hippocampal primary cultures
proposed that Stx-4 is critically involved in the activity-depen-
dent exocytosis of a transferrin-EGFP fusion protein that is
used as a proxy for AMPARs in dendritic spines and thus sug-
gested that Stx-4 plays a role in AMPAR trafficking in LTP (Ken-
nedy et al., 2010). A more direct investigation of syntaxins in
LTP using acute hippocampal slices, however, showed that it
was Stx-3, not Stx-4, that mediates AMPAR-containing vesicle
exocytosis in LTP (Jurado et al., 2013). Since we now, using a
different preparation (cultured hippocampal slices), suggest
that Stx-4 is critical for RA-triggered AMPAR exocytosis, we
were concerned that differences between previous studies
may have been due to differences in the experimental approach
instead of true differences in biological processes. To address
this concern, we repeated the LTP experiments with syntaxin
KD in our cultured hippocampal slices, with the aim to directly
compare the apparently distinct roles of Stx-3 and Stx-4 in
two different types of plasticity in the same preparation. We
found that, as with acute slices (Jurado et al., 2013), Stx-3,
but not Stx-4, was essential for hippocampal LTP (Figures 5D
and 5E) (control, 264.63% ± 24.13%; Stx-3 KD, 142.55% ±
23.55%; Stx-4 KD, 260.35% ± 48.76%). Taken together, these
results suggest the intriguing possibility that RA-induced
AMPAR exocytosis is mediated by a novel activity-dependent
trafficking pathway that is mechanistically distinct from the
LTP pathway or from the constitutive ANPAR exocytosis
pathway. While the LTP- and RA-induced AMPAR exocytosis
pathways share two SNARE proteins, Syb-2 and SNAP-47,
they utilize distinct syntaxins, which may play a role in defining
these distinct pathways.
Cpx-Binding Sequence of Stx-3 Blocks RA-Mediated
Synaptic Delivery of AMPARs
Stx-1 and Stx-3 contain a Cpx-binding sequence in the SNARE
motif, whereas Stx-4 does not (Figures 5A–5C; Pabst et al.,
2000). Cpx binding to Stx-1 and Stx-3 is required for their
respective functions in neurotransmitter release and LTP (Ju-
rado et al., 2013; Su¨dhof and Rothman, 2009). Although wehave shown that Cpx is not required for RA-mediated AMPAR
delivery to the synapse, we were curious as to whether
Stx-4’s inability to bind Cpx is important for its function in RA-
mediated AMPAR insertion. We addressed this question by
swapping the Cpx-binding sequence of Stx-3 (amino acids
213–224) with the homologous sequence of Stx-4 that does
not interact with Cpx, resulting in two chimeric proteins: a
Stx-4 that now binds Cpx (Stx-4/3) and a Stx-3 that no longer
binds Cpx (Stx-3/4). Then, we tested the ability of these two
chimeras to rescue the effect of the Stx-4 KD on RA-induced
AMPAR insertion. In contrast to a shRNA-resistant wild-type
Stx-4 rescue construct (Stx-4 Rep), which fully rescued the ef-
fect of RA on AMPAR-mediated synaptic transmission (Fig-
ure 6A) (control/DMSO, 10.25 ± 0.22 pA; control/RA, 12.23 ±
0.23 pA; Stx-4 Rep/DMSO, 10.36 ± 0.33 pA; Stx-4 Rep/RA,
11.88 ± 0.26 pA), mutant Stx-4/3 failed to restore the RA-
induced increase in AMPAR mEPSC amplitude (Figure 6B)
(control/DMSO, 10.65 ± 0.21 pA; control/RA, 12.48 ± 0.36 pA;
Stx-4/3 rescue constructs (Stx-4/3 Rep)/DMSO, 11.06 ±
0.25 pA; Stx-4/3 Rep/RA, 10.22 ± 0.30 pA). This result indicates
that lack of Cpx binding is, indeed, an important functional
feature of Stx-4 for its role in mediating RA-induced, activity-
regulated AMPAR insertion. We also tested the reverse chimera,
Stx-3/4, where the Stx-3 Cpx-binding sequence is replaced by
the homologous sequence in Stx-4 that does not interact with
Cpx. This rescue construct also failed to reverse the Stx-4 KD
phenotype; RA was still unable to increase mEPSCs amplitude
in neurons expressing this chimera (Figure 6C) (control/DMSO,
10.37 ± 0.40 pA; control/RA, 12.89 ± 0.52 pA; Stx-3/4 rescue
constructs (Stx-3/4 Rep)/DMSO, 10.43 ± 0.41 pA; Stx-3/4
Rep/RA, 10.42 ± 0.26 pA). Thus, additional Stx-4-specific func-
tional sequence motifs besides the absence of Cpx-binding
sequence are required for the RA-mediated, activity-dependent
synaptic delivery of AMPARs.
Blocking Stx-4-Mediated AMPAR Synaptic Delivery
Rescues LTP after RA Treatment
Our molecular dissection of the AMPAR exocytosis mechanisms
revealed a novel AMPAR insertion pathway that is regulated by
synaptic activity. However, it remains undetermined how RA
treatment blocks subsequent development of LTP (see Figure 1).
One possibility is that, because the RA and LTP pathways
converge onto the same final common step—an increase in
AMPAR content at synapses—these two processes occlude
each other either because of depletion of the AMPARs in the
reserve pool or because of the filling of the synaptic slots that
are required for receiving AMPARs at synapses. If one of
these hypotheses is correct, selectively preventing RA-induced
AMPAR exocytosis, but not LTP-induced AMPAR exocytosis,
should rescue the block of LTP by RA. However, it is also
possible that RA has additional unknown effects in a neuron
that somehow compromise LTP signaling pathways upstream
to AMPAR insertion. If this were the case, preventing AMPAR
insertion during RA treatment should not rescue LTP.We directly
tested this possibility by examining LTP in Stx-4 KD neurons
that were treated with RA. Both DMSO- and RA-treated
neurons receiving Stx-4 KD expressed normal LTP (Figures 7A
and 7B) (Stx-4 KD/DMSO, 349.17% ± 43.90%; Stx-4 KD/RA,Neuron 86, 442–456, April 22, 2015 ª2015 Elsevier Inc. 451
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Figure 6. Non-Cpx-Binding Sequence of Stx-4 Is Required for Normal Stx-4 Function in RA-Induced AMPAR-Containing Vesicle Exocytosis
(A) Analysis of amplitude and frequency of mEPSCs obtained from CA1 pyramidal neurons expressing both Stx-4 KD and Stx-4 Rep (*p < 0.05; ***p < 0.001; n.s.,
not significant). Top: schematic of Stx-4 showing its functional domains (red indicates non-Cpx-binding sequence). Habc, Habc domains; TMR, transmembrane
domain.
(B) Analysis of amplitude and frequency of mEPSCs obtained from CA1 pyramidal neurons expressing both Stx-4 KD and Stx-4/3 Rep (***p < 1 3 104). Top:
schematic of Stx-4/3 showing that the non-Cpx-binding domain of Stx-4 is replaced by the Cpx-binding domain of Stx-3 (green).
(C) Analysis of amplitude and frequency of mEPSCs obtained from CA1 pyramidal neurons expressing both Stx-4 KD and Stx-3/4 Rep (***p < 0.001; n.s., not
significant). Top: schematic of Stx-3/4 showing that the Cpx-binding domain of Stx-3 is replaced by the non-Cpx-binding domain of Stx-4 (red).421.29% ± 79.01%). Thus, RA treatment impairs subsequent
LTP induction through its effect on the step of AMPAR synaptic
delivery.
DISCUSSION
The connectivity of a neural network can be modified by
at least two major forms of long-lasting plasticity: Hebbian
and homeostatic plasticity. Although operating under opposite
computational mechanisms (positive feedback mechanisms
for Hebbian plasticity versus negative feedback mechanisms
for homeostatic plasticity), these two types of plasticity likely
interact at multiple points at the biochemical, molecular, and
structural levels, altering parameters such as neuronal excit-
ability through modulation of expression levels of ion channels
(Campanac and Debanne, 2007; Magee and Johnston, 2005),
synaptic strength through modulation of release probability
and postsynaptic receptor abundance (Davis and Muller,
2015; Grasselli and Hansel, 2014; Huganir and Nicoll, 2013),
and—at a longer timescale—number of synaptic contacts
through modulation of synapse formation and elimination
(Bourne and Harris, 2008; Sala and Segal, 2014; Yu and Zuo,452 Neuron 86, 442–456, April 22, 2015 ª2015 Elsevier Inc.2011). In the present study, we dissected the AMPAR traf-
ficking mechanisms involved in RA-dependent homeostatic
plasticity and compared these mechanisms to those involved
in LTP. Moreover, we examined the intersection of the mecha-
nisms mediating RA- and LTP-induced AMPAR-trafficking
and focused on the interaction between synaptic RA signaling
and LTP.
We found that increasing excitatory synaptic strength through
synaptic RA signaling impaired subsequent induction of LTP at
hippocampal synapses through a mechanism that is mediated
by the RA receptor RARa and requires protein synthesis. In
further exploring the molecular mechanism of such interaction,
we made two unexpected discoveries. First, although RA
synthesis in neurons seems to be triggered by reduced synaptic
activity (Wang et al., 2011), RA-induced insertion of AMPARs
into synapses, paradoxically, requires activity and NMDAR
activation. Second, RA-induced exocytosis of AMPAR-con-
taining vesicles requires a SNARE-dependent membrane-
fusion machinery (Syb-2, SNAP-47, and Stx-4, but not Cpx)
whose components only partially overlap with those involved
in LTP-induced exocytosis of AMPAR-containing vesicles
(Syb-2, SNAP-47, and Stx-3, with Cpx), thus revealing a novel
pairing
0
100
200
300
400
E
P
S
C
 (%
)
500
600
0 20 40 60
Time (min)
stx4 KD/DMSO
stx4 KD/RA
0
200
800
400E
P
S
C
 (%
) 600
DMSO
(n = 18)
RA
(n = 11)
A B
Figure 7. Stx-4 KD Rescues LTP in RA-Treated Hippocampal Slices
(A) Summary graph (left) and trace examples (right) of LTP recorded from Stx-4 KD CA1 pyramidal neuron treated with DMSO or RA. Black bar in the summary
graph represents the time window for LTP magnitude quantification. Scale bars, 50 pA, 10 ms.
(B) Scatterplots of LTP obtained from individual experiments summarized in (A), with bar graphs representing mean ± SEM (p > 0.05).activity-regulated AMPAR trafficking pathway that is distinct
from the LTP pathway.
AMPAR Trafficking in RA- and LTP-Induced Synaptic
Potentiation Requires Distinct SNARE-Dependent
Vesicle Fusion Machineries
The speed and precision required for presynaptic neurotrans-
mitter release makes it an attractive system for studying vesicle
fusion and deciphering the regulatory mechanisms that gate
the fusion event. Indeed,wehavea reasonably goodunderstand-
ing of the molecular players required for Ca2+-regulated exocy-
tosis of synaptic vesicles (Rizo and Rosenmund, 2008; Su¨dhof,
2013; Su¨dhof and Rothman, 2009). However, although it has
been long accepted that Ca2+ is also a key element in the re-
gulation of biochemical processes in postsynaptic compart-
ments, and that activity-regulated postsynaptic exocytosis likely
requires SNAREs and SNARE-binding proteins, we are just
beginning to identify individual components required for various
postsynaptic vesicle exocytosis events. For example, Cpx plays
multiple roles in neurotransmitter release, including vesicle prim-
ing (Yang et al., 2010), activation of SNARE complexes before
vesicle fusion (Maximov et al., 2009; Reim et al., 2001; Xue
et al., 2009), and clamping of SNARE complexes to prevent inap-
propriate fusion (Giraudo et al., 2006; Huntwork and Littleton,
2007; Maximov et al., 2009; Tang et al., 2006; Xue et al., 2009;
Yang et al., 2010). The role of Cpx in postsynaptic AMPAR-con-
taining vesicle exocytosis during LTP was recently documented
and is thought to function by binding to the Q-SNARE Stx-3
instead of Stx-1 (Ahmad et al., 2012), thus expanding the reper-
toire of Cpx functions to postsynaptic vesicular trafficking.
Notably, for RA-mediated AMPAR trafficking during non-Heb-
bian plasticity, not only is Cpx binding unnecessary, but it may
also ‘‘clamp’’ the fusion event and prevent it from occurring
when a Cpx-binding sequence is introduced into Stx-4 (Fig-
ure 6B). These results raise the possibility that Cpx bindingmight
help define a subpopulation of postsynaptic AMPAR-containing
vesicles that is exclusively involved in LTP but not in homeostatic
or other activity-dependent forms of plasticity. This notion is
supported, in part, by our observation that the non-Cpx-bindingStx-4 is selectively required for RA-induced AMPAR insertion,
instead of Stx-3, which is required for LTP, or Stx-1, which is
required for presynaptic vesicle fusion. Thus, one attractive
model for the differential regulation of postsynaptic activity-regu-
lated AMPAR exocytosis is that Stx-3 and Stx-4 define separate
vesicle fusion sites on the target plasma membrane for insertion
of AMPAR-containing vesicles. During LTP, AMPAR-containing
vesicles associate with Cpx, and they dock and exocytose at
Stx-3-rich membrane sites, whereas during synaptic RA sig-
naling, non-Cpx-associated AMPAR-containing vesicles dock
and exocytose at Stx-4-rich membrane sites (Figure 8).
Despite the mechanistic similarities between pre- and post-
synaptic SNARE-mediated vesicle exocytosis, these processes
exhibit important differences that involve distinct molecular
mechanisms, possibly for the purpose of differentially regulating
these processes. To support presynaptic transmitter release,
which is triggered rapidly (<1 ms) by calcium at the active
zone, intricate presynaptic scaffold structures are required for
docking and priming of synaptic vesicles (Su¨dhof, 2013). By
contrast, ultrastructural studies failed to observe docked
AMPAR-containing vesicles on the postsynaptic membranes,
either because postsynaptic fusion events are much less
frequent than those that occur at presynaptic site or because
calcium-triggered postsynaptic vesicle exocytosis during LTP
may occur at a slower time course (Makino and Malinow,
2009; Patterson et al., 2010; Petrini et al., 2009; Yudowski
et al., 2007). Findings from the present study add another level
of complexity to the picture by revealing a second form of activ-
ity-regulated, AMPAR-containing vesicle exocytosis, mediated
by a different syntaxin than that used by the LTP pathway. Addi-
tionally, SNAP-47, the other Q-SNARE required for both post-
synaptic vesicle exocytosis processes, may be partly soluble
compared to the permanently membrane-localized SNAP-25 at
the presynaptic side (Holt et al., 2006). Therefore, more work is
required to determine whether postsynaptic vesicle exocytosis
sites for the LTP and RA pathways are permanent or transient.
How does RA-induced AMPAR insertion block subsequent
development of LTP? One possibility is that the AMPAR-con-
taining vesicle pool is a limiting factor. RA induces synapticNeuron 86, 442–456, April 22, 2015 ª2015 Elsevier Inc. 453
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Figure 8. Model of the Shared and Distinct
Vesicle Fusion Machinery for AMPAR-Con-
taining Vesicle Exocytosis during LTP and
Synaptic RA Signaling
Top: R-SNARE Syb-2 is present in the membrane
of AMPAR-containing vesicles. Stx-3 and Stx-4
may form distinct vesicle fusion micro-domains on
the synaptic or perisynaptic membranes and
define AMPAR-containing vesicle exocytosis
locations for LTP and RA pathways, respectively.
Q-SNARE SNAP-47 is present and is required
for both pathways. Bottom: AMPAR-containing
vesicle fusion occurs at distinct surfacemembrane
locations during LTP or RA signaling. RA-induced
vesicle exocytosis occludes LTP by either
depleting the AMPAR-containing vesicle pool or
by occupying postsynaptic slots necessary for
anchoring AMPARs.incorporation of GluA2-lacking AMPARs (Aoto et al., 2008;
Maghsoodi et al., 2008; Wang et al., 2011). Similarly, LTP has
been proposed to induce the insertion of GluA2-lacking AMPARs
(Guire et al., 2008; Morita et al., 2014; Plant et al., 2006; but see
Adesnik and Nicoll, 2007; Gray et al., 2007). Therefore, it is
possible that the two processes share and compete for the
same GluA2-lacking AMPAR vesicle pool. Local biochemical
events specifically associated with each type of plasticity could
direct these vesicles for fusion with a Cpx/Stx-3-dependent
mechanism for the LTP pathway or fusion with a Cpx-indepen-
dent, Stx-4-dependentmechanism for theRApathway (Figure 8).
Alternatively, the AMPAR vesicles used for each pathway may
differ. Instead, the synaptic ‘‘slots’’ available for stabilizing newly
inserted AMPARs could be limiting. It is, then, possible that RA-
induced AMPAR insertion into synapses occupies these slots
and prevents subsequent LTP (Figure 8). Further experiments
are required to distinguish between these two possibilities.
Activity Dependence of RA-Mediated AMPAR
Trafficking
An intriguing finding in the present study is the requirement of
neuronal activity and NMDAR activation for RA-induced AMPAR
insertion—a process that has much similarity with the LTP
pathway, except in the molecular constituents of the fusion ma-
chinery. The function of RA in synaptic signaling was discovered
in the context of homeostatic synaptic plasticity, namely, the454 Neuron 86, 442–456, April 22, 2015 ª2015 Elsevier Inc.synaptic-inactivity-induced upregulation
of synaptic strength (Aoto et al., 2008;
Wang et al., 2011). RA synthesis is trig-
gered by reduced dendritic Ca2+ (Wang
et al., 2011). Here, our findings suggest
that, once RA is made and synthesis of
new AMPARs is activated by RA, AMPAR
incorporation into the existing synapses
is not merely a default step. Instead, ac-
tivity and NMDAR activation are required
to execute the final step of receptor local-
ization to the synapse. Thus, homeostatic
synaptic plasticity, at least the form that ismediated by RA signaling, seems to require twomajor regulatory
steps. The first step is the prolonged-inactivity-triggered RA pro-
duction and AMPAR synthesis, a step that ‘‘primes’’ the postsyn-
aptic neurons for rapid strengthening of excitatory synapses.
However, AMPARs are not ‘‘blindly’’ inserted into all existing
excitatory synapses. The second step is an execution step that
inserts AMPARs to functional synapses via a validation pro-
cess—brief activation of the synapse (mediated by NMDAR acti-
vation and a transient postsynaptic Ca2+ rise) that is indicative of
a functional synapse. The execution step ensures insertion of
AMPARs into synapses that are part of a functional circuit.
Whatmight be the advantage of having such an additional syn-
aptic function ‘‘checkpoint’’ for homeostatic synaptic plasticity?
Conceptually, the role of homeostatic plasticity in a neural
network is to compensate for prolonged changes in the input ac-
tivity that deviates from its optimal range (too high or too low). In
the case of prolonged reduction in input activity, inputs that are
experiencing reduced upstream activity (thus representing
weaker, but still functional, input) and those that are experiencing
permanent loss of input activity (thus destined to be eliminated)
can both contribute to the activation of homeostatic compensa-
tion mechanisms (i.e., RA synthesis). As such, it is, perhaps,
most effective if compensation through an increase in postsyn-
aptic receptor number occurs at synapses where active presyn-
aptic release still occurs (albeit, at a reduced level), as opposed
to synaptic contacts that are destined to be removed. A
validation step using NMDAR activity acts as an ideal switch to
permit activity-regulated exocytosis of AMPAR-containing vesi-
cles at functional synapses. Such selective strengthening of all
functional connections renormalizes the synaptic strength of a
network to allow readjustment of an optimal dynamic range of
activity for all meaningful connections while leaving the nonfunc-
tional ones out. Furthermore, this validation process might, in
fact, support the phenomenon of ‘‘synaptic scaling,’’ in which
synapses of different sizes increase their strength in a multiplica-
tive fashion during homeostatic upregulation, as previously
proposed based on observations in cultured cortical neuron
networks (Turrigiano et al., 1998). If the AMPAR insertion into
functional synapses is regulated by local synaptic activity (and,
presumably, local Ca2+ influx), it is conceivable that bigger
synapses with more NMDARs can potentially gain more new
AMPARs than smaller ones, thus providing a biochemical mech-
anism for synaptic scaling.
In summary, our findings suggest that the functional impact of
RA at synapses goes beyond homeostatic plasticity and that,
despite the divergence in the molecular mechanisms underlying
Hebbian and homeostatic plasticity, these two major forms of
synaptic plasticity interact functionally (Arendt et al., 2013; Toyoi-
zumi et al., 2014). Additionally, the findings presented here pro-
vide concrete molecular tools that can be used for future work
to investigate the function of synaptic RA signaling and homeo-
static synaptic plasticity in vivo in the context of animal learning.
EXPERIMENTAL PROCEDURES
The RARa floxed mouse is a gift from Drs. Pierre Chambon and Norbert Ghy-
selinck (IGBMC, Strasbourg, France) (Chapellier et al., 2002). Breeding col-
onies are maintained in the animal facility at Stanford Medical School following
standard procedures approved by the Stanford University Administrative
Panel on Laboratory Animal Care. Organotypic slice cultures were prepared
from RARa floxed mice (postnatal days 6–7) and maintained for 5–7 days prior
to recording (Aoto et al., 2008; Arendt et al., 2013).
Full experimental procedures and associated references are available in the
Supplemental Information.
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